全文获取类型
收费全文 | 13516篇 |
免费 | 760篇 |
国内免费 | 56篇 |
专业分类
耳鼻咽喉 | 173篇 |
儿科学 | 511篇 |
妇产科学 | 292篇 |
基础医学 | 1974篇 |
口腔科学 | 219篇 |
临床医学 | 1448篇 |
内科学 | 2869篇 |
皮肤病学 | 245篇 |
神经病学 | 1393篇 |
特种医学 | 352篇 |
外科学 | 1415篇 |
综合类 | 80篇 |
一般理论 | 9篇 |
预防医学 | 1064篇 |
眼科学 | 220篇 |
药学 | 944篇 |
中国医学 | 53篇 |
肿瘤学 | 1071篇 |
出版年
2023年 | 91篇 |
2022年 | 184篇 |
2021年 | 376篇 |
2020年 | 228篇 |
2019年 | 357篇 |
2018年 | 392篇 |
2017年 | 265篇 |
2016年 | 306篇 |
2015年 | 392篇 |
2014年 | 517篇 |
2013年 | 721篇 |
2012年 | 1043篇 |
2011年 | 1107篇 |
2010年 | 588篇 |
2009年 | 516篇 |
2008年 | 843篇 |
2007年 | 917篇 |
2006年 | 849篇 |
2005年 | 799篇 |
2004年 | 730篇 |
2003年 | 716篇 |
2002年 | 639篇 |
2001年 | 112篇 |
2000年 | 99篇 |
1999年 | 126篇 |
1998年 | 140篇 |
1997年 | 113篇 |
1996年 | 77篇 |
1995年 | 86篇 |
1994年 | 69篇 |
1993年 | 55篇 |
1992年 | 83篇 |
1991年 | 68篇 |
1990年 | 52篇 |
1989年 | 54篇 |
1988年 | 51篇 |
1987年 | 42篇 |
1986年 | 47篇 |
1985年 | 39篇 |
1984年 | 45篇 |
1983年 | 46篇 |
1982年 | 45篇 |
1981年 | 45篇 |
1980年 | 38篇 |
1979年 | 35篇 |
1978年 | 28篇 |
1977年 | 17篇 |
1976年 | 15篇 |
1975年 | 20篇 |
1972年 | 17篇 |
排序方式: 共有10000条查询结果,搜索用时 406 毫秒
1.
Deitelzweig Steve Luo Xuemei Nguyen Jennifer L. Malhotra Deepa Emir Birol Russ Cristina Li Xiaoyan Lee Theodore C. Ferri Mauricio Wiederkehr Danny Reimbaeva Maya Barnes Geoffrey D. Piazza Gregory 《Journal of thrombosis and thrombolysis》2022,54(4):696-696
Journal of Thrombosis and Thrombolysis - 相似文献
2.
3.
Lara Silveira Abdo Aguiar Rita de Cssia Rossini Lismary Aparecida de Forville Mesquita Gerson Dellatorre 《Journal of Cosmetic Dermatology》2019,18(6):1733-1736
Depigmented lesions may occur as postinflammatory sequelae of subacute cutaneous lupus erythematosus (SCLE), leading to great psychosocial impact. A 53‐year‐old male patient presented with post‐SCLE depigmented facial lesions after five years of disease stability. We proposed surgical treatment with melanocyte‐keratinocyte transplantation procedure (MKTP), and after five months the patient achieved 90% repigmentation, without Koebner phenomenon (KP). In theory, KP is a possible complication of MKTP procedure since the preparation of the receptor area involves the use of dermabrasion. In an attempt to avoid it, we suggest to maintain the treatment of the underlying disease and wait for a minimum period of disease stability before the procedure. 相似文献
4.
Angela Mauro Salvatore Mauro Roberto Rega Luigi Martemucci Rita Sottile 《Pediatric dermatology》2019,36(1):e34-e36
Henoch‐Schonlein purpura (HSP) is the most common systemic vasculitis in childhood. There is no consensus about the management for isolated cutaneous manifestations in HSP. We describe a case of HSP presenting with severe skin lesions that did not respond to standard therapy with corticosteroids. The 11‐year‐old child was treated with intravenous immunoglobulins, which induced rapid and persistent resolution of symptomatology. 相似文献
5.
Alessia Scarselli Silvia Di Cesare Claudia Capponi Simona Cascioli Maria L. Romiti Gigliola Di Matteo Alessandra Simonetti Paolo Palma Andrea Finocchi Barbarella Lucarelli Rita M. Pinto Ippolita Rana Giuseppe Palumbo Maurizio Caniglia Paolo Rossi Rita Carsetti Caterina Cancrini Alessandro Aiuti 《Journal of clinical immunology》2015,35(4):373-383
6.
7.
Ramya C. Mosarla Muthiah Vaduganathan Arman Qamar Javid Moslehi Gregory Piazza Robert P. Giugliano 《Journal of the American College of Cardiology》2019,73(11):1336-1349
Patients with active cancer are at an increased risk of arterial and venous thromboembolism (VTE) and bleeding events. Historically, in patients with cancer, low molecular weight heparins have been preferred for treatment of VTE, whereas warfarin has been the standard anticoagulant for stroke prevention in patients with atrial fibrillation (AF). More recently, direct oral anticoagulants (DOACs) have been demonstrated to reduce the risk of venous and arterial thromboembolism in large randomized clinical trials of patients with VTE and AF, respectively, thus providing an attractive oral dosing option that does not require routine laboratory monitoring. In this review, we summarize available clinical trial data and guideline recommendations, and outline a practical approach to anticoagulation management of VTE and AF in cancer. 相似文献
8.
A. Montalto V. Piazza F. Albi R. Gherli C. Contento A. Palermo F. Musumeci 《Transplantation proceedings》2019,51(1):206-209
Background
Pump speed optimization in patients implanted with a ventricular assist device represents a major challenge during the follow-up period. We present our findings on whether combined invasive hemodynamic ramp tests and cardiopulmonary exercise testing (CPX) can help optimize patient management.Methods
Eighteen patients implanted with a HeartMate 3 (HM3) device underwent ramp tests with right heart catheterization (including central venous pressure [CVP], pulmonary artery pressure, pulmonary capillary wedge pressure [PCWP], and blood pressure) and echocardiography. Data were recorded at up to 4 speed settings. Speed changes were in steps of 200 revolutions/min (rpm). Evaluation of functional capacity by CPX was conducted according to the modified Bruce protocol.Results
Only 30% of patients had normal PCWPs at their original rpm settings. In going from lowest to highest speeds, cardiac output improved by 0.25 ± 0.35 L/min/step (total change, 1.28 ± 0.3 L/min), and PCWP decreased by 1.9 ± 0.73 mm Hg/step (total change, 6 ± 1.6 mm Hg). CVP and systolic blood pressure did not change significantly with rpm. The rpm assessment was adjusted based on test results to achieve CVPs and PCWPs as close to normal limits as possible, which was feasible in all patients. On CPX, all patients demonstrated good performance (peak VO2, 16.8 ± 3.5 mL/kg/min).Conclusion
Hemodynamic ramp testing provides an objective means of optimizing rpm, and has the potential to provide good exercise tolerance. 相似文献9.